Скачать
Dr Jen on the Efficacy of an All-Oral, Revumenib-Containing Regimen in AML
Автор: OncLive
Загружено: 2025-12-07
Просмотров: 30
Описание:
Wei Ying Jen, MA, BM BCh, M Med, MRCP, FRCPath, an assistant professor in the Department of Leukemia in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, discussed findings from the phase 2 SAVE trial (NCT05360160) evaluating revumenib (Revuforj) plus decitabine, cedazuridine, and venetoclax (Venclexta) in patients with newly diagnosed acute myeloid leukemia.
See our site for more highlights from the 2025 ASH Annual Meeting: https://www.onclive.com/conference/ash
Website: https://www.onclive.com
Twitter: / onclive
Facebook: / onclive
LinkedIn: / onclive
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
